Chemoresistance in non-small cell lung cancer
P Sève, C Dumontet - Current Medicinal Chemistry-Anti-Cancer …, 2005 - ingentaconnect.com
The treatment of advanced non-small-cell lung cancer (NSCLC is based on the combination
of platin and one of the following agents: taxanes, gemcitabine, vinorelbine or irinotecan …
of platin and one of the following agents: taxanes, gemcitabine, vinorelbine or irinotecan …
Microtubulin binding sites as target for developing anticancer agents
M Islam, MN Iskander - Mini reviews in medicinal chemistry, 2004 - ingentaconnect.com
Microtubules (MTs) play important and diverse roles in eukaryotic cells. Their function and
biophysical properties have made α-and β-tubulin, the main components of MTs, the subject …
biophysical properties have made α-and β-tubulin, the main components of MTs, the subject …
D-24851, a Novel Synthetic Microtubule Inhibitor, Exerts Curative Antitumoral Activity in Vivo, Shows Efficacy toward Multidrug-resistant Tumor Cells, and Lacks …
G Bacher, B Nickel, P Emig, U Vanhoefer, S Seeber… - Cancer research, 2001 - AACR
Abstract N-(pyridin-4-yl)-[1-(4-chlorbenzyl)-indol-3-yl]-glyoxyl-amid (D-24851) is a novel
synthetic compound that was identified in a cell-based screening assay to discover cytotoxic …
synthetic compound that was identified in a cell-based screening assay to discover cytotoxic …
Vinca alkaloids as a potential cancer therapeutics: recent update and future challenges
A Banyal, S Tiwari, A Sharma, I Chanana, SKS Patel… - 3 Biotech, 2023 - Springer
Vinca alkaloids including vincristine, vinblastine, vindesine, and vinflunine are
chemotherapeutic compounds commonly used to treat various cancers. Vinca alkaloids are …
chemotherapeutic compounds commonly used to treat various cancers. Vinca alkaloids are …
Signal transduction pathways of taxanes-induced apoptosis
V Ganansia-Leymarie, P Bischoff… - … -Anti-Cancer Agents, 2003 - ingentaconnect.com
Docetaxel (Taxotere) is a member of the taxane class of anticancer agents to reach clinical
use. This semisynthetic analog of paclitaxel (Taxol) is one of the newer potent anti …
use. This semisynthetic analog of paclitaxel (Taxol) is one of the newer potent anti …
Vincamine, from an antioxidant and a cerebral vasodilator to its anticancer potential
Vincamine is a naturally occurring indole alkaloid showing antioxidant activity and has been
used clinically for the prevention and treatment of cerebrovascular disorders and …
used clinically for the prevention and treatment of cerebrovascular disorders and …
Vinorelbine in previously treated advanced childhood sarcomas: Evidence of activity in rhadbomyosarcoma
M Casanova, A Ferrari, F Spreafico, M Terenziani… - Cancer, 2002 - Wiley Online Library
BACKGROUND Vinca alkaloids have proved active against a number of pediatric
malignancies. The aim of this study was to assess the feasibility and effectiveness of using …
malignancies. The aim of this study was to assess the feasibility and effectiveness of using …
Vinorelbine in cancer therapy
A Capasso - Current drug targets, 2012 - ingentaconnect.com
Vinorelbine is an antimitotic anticancer agent and its main mechanism of action is related to
the inhibition of microtubule dynamics leading to a mitotic arrest and cell death. Vinorelbine …
the inhibition of microtubule dynamics leading to a mitotic arrest and cell death. Vinorelbine …
Fatty Acid Synthase Inhibitors Enhance Microtubule-Stabilizing and Microtubule-Destabilizing Drugs in Taxane-Resistant Prostate Cancer Cells
JJ Souchek, A Laliwala, L Houser… - ACS Pharmacology & …, 2023 - ACS Publications
Prostate cancer is the third leading cause of cancer-related death in men in the United
States. Taxane chemotherapy is a staple therapy for men with metastatic prostate cancer, yet …
States. Taxane chemotherapy is a staple therapy for men with metastatic prostate cancer, yet …
Antibody drug conjugates: Progress, pitfalls, and promises
A Mukherjee, AK Waters, I Babic… - Human …, 2019 - content.iospress.com
Antibody drug conjugates (ADCs) represent a promising and an efficient strategy for
targeted cancer therapy. Comprised of a monoclonal antibody, a cytotoxic drug, and a linker …
targeted cancer therapy. Comprised of a monoclonal antibody, a cytotoxic drug, and a linker …